Anti-EGFR conjugated nanoparticles to deliver Alpelisib as targeted therapy for head and neck cancer

Juan, A.; Segrelles, C.; del Campo-Balguerías, A.; Bravo, I.; Silva, I.; Peral, J.; Ocaña, A.; Clemente-Casares, P.; Alonso-Moreno, C.; Lorz, C.
https://doi.org/10.1186/s12645-023-00180-z